Turkey tail mushroom extracts have been used for decades alongside surgery, chemotherapy, and radiotherapy to support the body's own defenses during cancer treatment. The most consistent signal is modestly longer survival when added after surgery for stomach and bowel cancer. It is well tolerated, mainly causing mild digestive effects, but may concern those on immune-suppressing drugs. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Complete blood count with differential | Neutrophils and lymphocytes within the mid-normal range | Tracks immune recovery and detects chemotherapy-related low counts |
| Liver enzymes (AST, ALT) | Roughly 10–30 U/L | Detects the rare transient enzyme elevation and monitors chemotherapy effects |
| Carcinoembryonic antigen (colorectal) | Ideally below about 3 ng/mL in non-smokers | Follows disease response and recurrence in colorectal cancer |
| Helper/killer T-cell ratio (CD4/CD8) | Approximately 1.5–2.5 | Reflects immune balance that cancer and chemotherapy tend to suppress |
Cadence: Complete blood count and liver enzymes at baseline, then approximately every 4–12 weeks during active adjuvant treatment; tumor-marker and imaging follow-up aligned with the oncology team (commonly every 3–6 months, then every 6–12 months).